Navin Fluorine (NAVINFLUOR) Q1 FY27: EBITDA Up 73%, Margin 34.2%

Navin Fluorine International (NAVINFLUOR) - Share price: ₹10,077 (screener.in, 21 November 2026) - Market cap: ₹51,710 crore - P/E: 56.4 (Gujarat Fluorochemicals 79.5, Pidilite 61.5 on screener.in) - ROCE: 21.0%

Navin Fluorine (NAVINFLUOR) grew Q1 FY27 operating profit 73% to ₹357 crore on 44% higher sales, lifting EBITDA margin to 34.2%.

Navin Fluorine Q1 FY27 investor presentation: results

Navin Fluorine sits in the Padmanabh Mafatlal Group. It describes nearly six decades of fluorine-chemistry experience. It makes refrigerant gases and inorganic fluorides (High Performance Products, HPP), fluorine-based specialty chemicals, and contract drug manufacturing (CDMO). The numbers below come from the investor presentation dated 5 August 2026 for the June 2026 quarter.

₹ crore (consolidated) Q1 FY26 Q1 FY27 Change ------------ Net revenue from operations 725.4 1,045.1 +44% Operating EBITDA 206.8 357.1 +73% Operating EBITDA margin 28.5% 34.2% +566 basis points Operating profit before tax 141.2 283.3 +101% Profit after tax 117.2 243.3 +108%

Why Navin Fluorine margins are expanding: three businesses growing at once

Each of the three businesses grew in Q1 FY27, and the two higher-margin ones grew fastest.

Business Q1 FY26 (₹ crore) Q1 FY27 (₹ crore) Growth Export share --------------- High Performance Products 407 540 +33% 54% Specialty Chemicals 219 325 +48% 62% CDMO 99 180 +82% 98%

- HPP: growth came from volume and higher prices. HFC refrigerant pricing is "constructive" as the world moves to low-warming gases, and customers show more interest in long-term offtake contracts for the new capacity. The anhydrous hydrofluoric acid (AHF) plant started in Q4 FY26 and is ramping up. - Specialty Chemicals: strong order visibility and new launches. - CDMO: backed by an order book. Most revenue comes from deeper work with one European CDMO major. About 98% of CDMO revenue is exported.

FY26 was already strong. Revenue was ₹3,313.9 crore (up 41% from ₹2,349.4 crore), operating EBITDA ₹1,081.7 crore (up 103%) and profit after tax ₹663.6 crore (up 130%). The EBITDA margin rose from 22.7% in FY25 to 32.6% in FY26 and 34.2% in Q1 FY27.

The growth driver in one line Navin's sales and margin are both rising because refrigerant prices are firm and the fastest-growing businesses, CDMO and specialty chemicals, earn more per rupee.

Navin Fluorine capex and new projects

Project Capex Due What it adds ------------ Extra HFC capacity, up to 15,000 tonnes a year of R32 ₹236.5 crore (own cash) Q3 FY27 Peak revenue about ₹600-825 crore a year MPP de-bottlenecking, Dahej ₹75 crore (own cash) Q3 FY27 Peak revenue about ₹140-160 crore a year; purchase order received for calendar 2026 cGMP4 Phase II (CDMO) ₹125 crore Q4 FY27 Asset turnover about 3 times; board had approved ₹288 crore for cGMP4 in February 2024 and Phase I started in Q3 FY26 Chemours liquid cooling project ₹120 crore (35% funded by customer) Q2 FY27 First commercial capacity for a data-centre cooling product Advanced Materials adoption capacity ₹90 crore Q2 FY28 Capacity to commercialise products for data centres, electronics, defence and semiconductors Renewable power SPV ₹15.73 crore for 14.9 MW n/a More than 60% of energy from renewable sources

Navin is also working on a project funded by India's Defence Research and Development Organisation (DRDO) to make a critical defence material in India.

How Navin Fluorine valuation compares with peers

Company Price (₹) P/E Market cap (₹ crore) ROCE --------------- Navin Fluorine 10,077 56.4 51,710 21.0% Gujarat Fluorochemicals 4,933 79.5 54,186 9.6% Pidilite Industries 1,620 61.5 1,65,004 31.0% Fine Organic 5,489 34.9 16,828 21.5% Aarti Industries 450 26.9 16,305 6.9% Deepak Nitrite 1,531 19.5 20,885 11.4%

Source: screener.in peer table, 21 November 2026 (consolidated). Gujarat Fluorochemicals is the closest direct peer. Navin trades at a lower P/E than it and a much higher ROCE. The same table already shows Navin's September 2026 quarter: sales ₹1,191 crore (up 57%) and net profit ₹269 crore (up 81.5%). This article covers the Q1 FY27 presentation only.

What Navin Fluorine management plans next

These are management's own forward-looking statements, not promises.

- Company guidance: none for revenue or profit. - HFC: extra capacity of up to 15,000 tonnes a year of R32 to start in Q3 FY27, with growing interest in long-term offtake. - Dahej MPP: de-bottlenecking in Q3 FY27 to support a new molecule for a global innovator. - CDMO: cGMP4 Phase II by Q4 FY27. Management keeps a mix of late-stage and early-stage molecules across oncology, respiratory, heart, brain and animal health. - Advanced Materials: a fourth vertical being "incubated" for data centres, electronics, defence and semiconductors. It runs the Chemours project (Q2 FY27), the DRDO project and the ₹90 crore adoption capacity (Q2 FY28). - Research: research and development spend was ₹48.71 crore in FY26, with three R&D centres (Surat, Dewas and Runcorn in the UK). - Energy: a hybrid power plant to meet over 60% of energy needs from renewables.

Navin Fluorine risks

- Customer concentration: the CDMO business depends heavily on one European CDMO major. - Many projects at once: HFC, MPP, cGMP4, Chemours, Advanced Materials and the power plant are all being built together. - Refrigerant pricing: HFC prices are "constructive" now. Margin depends on that staying true. - Valuation: a P/E of 56.4 prices in the growth. - Margin held, not rising: operating margin was 34.2% in Q1 FY27 against 34.2% in Q4 FY26 (down 8 basis points).

Note: I am not a SEBI-registered investment advisor. This article is for educational purposes only and is not investment advice. Please consult a registered financial advisor before making investment decisions.

Sources

- https://nsearchives.nseindia.com/corporate/NAVINFLUOR05082026164351Binder1.pdf (Navin Fluorine Q1 FY27 investor presentation, 5 August 2026)